Only 34% of GLP-1 patients on DPP-4 inhibitors, a class of oral diabetic medications also known as gliptins, were still taking DPP-4 inhibitors 52 weeks after starting GLP-1 therapy according to Earnest pharmacy claims data
Were proud to have Adam representing Direct Meds and sharing his expertise with the industry If youre attending, reach out to Adam Pivko, MBA to connect #AffiliateWorld #AWConferences #DirectMeds #PerformanceMarketing #DTC #Ecommerce Were incredibly proud to see our Chief Marketing Officer, Adam Pivko, MBA , representing Direct Meds on stage at this years SubSummit in Kansas City
Cartilage degeneration was markedly reduced in CCR5 -/- mice affected by post-traumatic OA, while mild changes appeared in osteophyte formation and synovitis compared to wild-types (64)
PMID: 227 LiYLinQLuXLiW
Current medical recommendations for semaglutide & breastfeeding As mentioned, the research into the risks of taking semaglutide while breastfeeding is ongoing
Yes, GLP-1 medications are administered via subcutaneous injection once weekly